BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7384555)

  • 1. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
    Lagarde M; Guichardant M; Ghazi I; Dechavanne M
    Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].
    Le Menn R; Migne J; Probst-Dvojakovic RJ
    Arzneimittelforschung; 1979; 29(8a):1278-82. PubMed ID: 540072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid.
    Vallee E; Gougat J; Ageron M
    Agents Actions; 1980 Apr; 10(1 Pt 2):57-62. PubMed ID: 7386309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of arachidonic acid metabolites by gas chromatography/mass spectrometry during platelet aggregation.
    Malle E; Leis HJ; Nimpf J; Gleispach H; Wurm H; Kostner GM
    Prog Clin Biol Res; 1987; 242():1-6. PubMed ID: 3478729
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP; Little DM; Wright JT
    Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation and reduced formation of thromboxane and lipoxygenase products in platelets by oil of cloves.
    Srivastava KC; Justesen U
    Prostaglandins Leukot Med; 1987 Sep; 29(1):11-8. PubMed ID: 3118394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium stimulates thromboxane B2 formation in human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
    Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Feb; 21(2):177-85. PubMed ID: 3083435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructural study of the action of a blood platelet anti-aggregant. Application to nicergoline].
    Le Menn R; Migne J; Prost-Dvojakovic RJ
    Therapie; 1977; 32(2):205-14. PubMed ID: 898128
    [No Abstract]   [Full Text] [Related]  

  • 14. Onion exerts antiaggregatory effects by altering arachidonic acid metabolism in platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Sep; 24(1):43-50. PubMed ID: 3094033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OKY-1581: a selective inhibitor of thromboxane synthesis in vivo and in vitro.
    Smith JB; Jubiz W
    Prostaglandins; 1981 Sep; 22(3):353-63. PubMed ID: 7302264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced incorporation of exogenous arachidonic acid into phosphatidylinositol and other phospholipids during the early stages of thrombin-induced aggregation in gerbil platelets.
    Agwu DE; Johnstone I; Crane S; Holub BJ
    Lipids; 1983 Dec; 18(12):859-62. PubMed ID: 6420635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets.
    Srivastava KC; Malhotra N
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):73-81. PubMed ID: 2011614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.